Compare FBRX & UMAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FBRX | UMAC |
|---|---|---|
| Founded | N/A | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 899.4M | 795.3M |
| IPO Year | 2017 | 2023 |
| Metric | FBRX | UMAC |
|---|---|---|
| Price | $56.63 | $19.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $67.00 | $20.00 |
| AVG Volume (30 Days) | 824.3K | ★ 4.3M |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 61.30 | ★ 80.73 |
| EPS | N/A | ★ 0.21 |
| Revenue | $36,000.00 | ★ $11,199,217.00 |
| Revenue This Year | N/A | $115.39 |
| Revenue Next Year | N/A | $101.44 |
| P/E Ratio | ★ N/A | $93.18 |
| Revenue Growth | N/A | ★ 101.23 |
| 52 Week Low | $9.25 | $7.25 |
| 52 Week High | $52.67 | $34.36 |
| Indicator | FBRX | UMAC |
|---|---|---|
| Relative Strength Index (RSI) | 86.71 | 48.59 |
| Support Level | $24.72 | $12.23 |
| Resistance Level | N/A | $20.15 |
| Average True Range (ATR) | 5.30 | 2.02 |
| MACD | 2.32 | -0.07 |
| Stochastic Oscillator | 99.06 | 37.26 |
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.
Unusual Machines Inc is engaged in manufactures and sells drone components and drones across a diversified brand portfolio through business-to-business (B2B) sales and a curated retail channel.